Moore Capital Management, LP Eli Lilly & CO Transaction History

Moore Capital Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $5.8 Million - $7.27 Million	-8,000 Reduced 27.59%	21,000 $19 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $14.8 Million - $19.8 Million	-25,000 Reduced 46.3%	29,000 $22.6 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $28.4 Million - $33.4 Million	54,000 New	54,000 $31.5 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $7.79 Million - $10.4 Million	22,200 New	22,200 $10.4 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.87 Million - $3.27 Million	9,680 Added 12.05%	89,980 $29.1 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $22.4 Million - $26.3 Million	80,300 New	80,300 $26 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $7.43 Million - $9.15 Million	-33,545 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $6.06 Million - $7.83 Million	33,545 New	33,545 $7.7 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $9.9 Million - $12.3 Million	-83,162 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $8.89 Million - $11 Million	83,162 New	83,162 $10.9 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $6.75 Million - $7.34 Million	-63,176 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.96 Million - $2.29 Million	-17,729 Reduced 21.91%	63,176 $7 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $3.85 Million - $4.53 Million	34,546 Added 74.52%	80,905 $10.5 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $4.91 Million - $5.5 Million	46,359 New	46,359 $5.37 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.